Navigation Links
Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting

poietin (EPO) and VTE in MM patients treated with anthracycline-based chemotherapy and the immunomodulatory agent thalidomide -- R. Baz; Abstract #8107; June 2, 2007; 8:00am-12:00pm; McCormick Place Convention Center, S HallA2

A pharmacogenetic study of docetaxel and thalidomide in patients with androgen-independent prostate cancer (AIPC) using targeted human DMET genotyping platform -- J. Deeken, MD; Abstract #3580; June 3, 2007; 8:00am- 12:00pm; McCormick Place Convention Center, S Hall A2

A phase II trial of thalidomide, bevacizumab, and docetaxel in patients (pts) with metastatic androgen-independent prostate cancer (AIPC) -- Y. Ning, MD; Abstract #5114; June 3, 2007; 2:00-6:00pm; McCormick Place Convention Center, S Hall A2

Factors predictive of outcome in relapsed, refractory MM patients treated with bortezomib, melphalan, prednisone and thalidomide (VMPT) -- A. Palumbo; Abstract #8048; June 4, 2007; 2:00-6:00pm; McCormick Place Convention Center, E451a

A systematic review of the incidence of venous thromboembolism (VTE) and effectiveness of prophylaxis in patients with multiple myeloma (MM) receiving thalidomide -- C. Wu, M.D.; Abstract #9056; June 4, 2007; 2:00-6:00pm; McCormick Place Convention Center, S Hall A2

A phase II trial of thalidomide (Thal) and procarbazine (Pro) in adults with recurrent or progressive malignant gliomas (MG) -- G. Lesser, MD; Abstract #2067; June 4, 2007; 1:00-5:00pm; McCormick Place Convention Center, S Hall A2

Satraplatin

Oral Presentation: Satraplatin demonstrates significant clinical benefits for the treatment of patients with HRPC: Results of a randomized phase III trial -- C. Sternberg; Abstract #5019; June 4, 2007; 11:00-11:15am; Arie Crown Theater

Amrubicin

A randomized phase II trial of Amrubicin vs. Topotecan as second-line treatment in extensive disease small-cell lung cancer (SCLC) sensitive to platinum-based first line chemotherapy. -- R.M. Jotte; Abstract
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference

Post Your Comments:
(Date:11/6/2009)...N, Mass., Nov. 6 DUSA Ph...ermatology company that is developing and marketin...ther products focused on patients with common skin...nd Chief Executive Officer, will present a corpora...ummit 2009 on Tuesday, November 10, 2009 at 10:00 ...
(Date:11/6/2009)... Fla., Nov. 6 Roper Ind...it has signed a definitive agreement to acquire Ve...dical devices. The Verathon Board of Directors ha...ect to customary regulatory approvals and closing ...arties expect the closing to be completed in early...
(Date:11/6/2009)..., Mass., Nov. 6 Facet Solutions, I...e assets of Archus Orthopedics. The acquisition cr... offerings, intellectual property and clinical exp... a win for patients suffering from lumbar spinal s...CEO, Geoff Pardo. "This consolidation further str...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Facet Solutions Acquires Archus Orthopedics 2Mexico Premiere for Money Saving Pharma Leak Testing Equipment 12573 1Mexico Premiere for Money Saving Pharma Leak Testing Equipment 12573 2Mexico Premiere for Money Saving Pharma Leak Testing Equipment 12573 3Clearly Contacts Announces Another Quarter Of Growth In The Economic Downturn 48555 1Clearly Contacts Announces Another Quarter Of Growth In The Economic Downturn 48555 2Clearly Contacts Announces Another Quarter Of Growth In The Economic Downturn 48555 3Omega 3 EPA 3A Treatment for a Heart Condition 48552 1Omega 3 EPA 3A Treatment for a Heart Condition 48552 2Omega 3 EPA 3A Treatment for a Heart Condition 48552 3Omega 3 EPA 3A Treatment for a Heart Condition 48552 4Omega 3 EPA 3A Treatment for a Heart Condition 48552 5Omega 3 EPA 3A Treatment for a Heart Condition 48552 6
...t. 19 Immtech Pharmaceuticals,Inc. (Amex: IMM ) ...stration,(FDA) has granted Orphan Drug Designation...n Trypanosomiasis (HAT), also known as African,sle...mmtech with numerous,financial and regulatory bene...overnment grants for conducting clinical trials, w...
...Presented at the 47th Annual Interscience Conferen...motherapy, LOUISVILLE, Colo., Sept. 19 Replidyne...eclinical studies, its,antibacterial candidate REP...e intestinal toxins caused by Clostridium difficil... disease (CDAD), an,inflammatory condition caused ...
Other Medicine Technology:US FDA Grants Orphan Drug Status to Immtech's Pafuramidine for Treatment of African Sleeping Sickness 2US FDA Grants Orphan Drug Status to Immtech's Pafuramidine for Treatment of African Sleeping Sickness 3Replidyne's Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile 2Replidyne's Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile 3Replidyne's Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile 4
(Date:11/7/2009)...The Public Relations Society of America (PRSA) wil...e Gage Lofgren, senior vice president of Brand Str..., tonight at a ceremony at PRSA,s 2009 Internation...nto the PRSA College of Fellows is one of the prof...Herman, APR, SAGE, Fellow PRSA, and 2009 chair of ...
(Date:11/7/2009)...o stem a growing problem across the U.S. , ...f of students at four-year colleges do it regularl...ng -- downing five or more alcoholic drinks at a s...ohol as a drug," said Jenny Hwang, associate dean ...at Stony Brook University on Long Island, N.Y. In ...
(Date:11/7/2009)... In the current economic climate, many Americ...re only spending money on what that they consider ...rgeon David D. Kim believes that it’s very ...o receive treatment to improve their health, and h... to patients in this tough economy by offering rea...
(Date:11/7/2009)... A new foot spray from Greensations fights pa... peppers and caffeine. ThermaFeet targets foot pai...t also contains Black Walnut, Goldenseal, Vitamin ... Schenectady, NY (PRWEB) November 7, 2009 -- A ...ncreases circulation with the power of hot peppers...
(Date:11/6/2009)...cently a Narconon of Georgia graduate was featured...escription drug abuse. The special report focused ...ction . In the report Andrew shared his near dea...one to prevent prescription drug abuse. ,, "I woke...ed my eyes to my father on top of me giving me CPR...
Breaking Medicine News(10 mins):Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3Health News:Hot Peppers and Caffeine Relieve Painful Feet, Toe Fungus and Foot Odor 2Health News:Narconon Drug Rehab of Georgia Graduate Featured on Local News 2
...Prominent New York personal injury lawyer reacts t... that cites major problems injured workers face wh...rk state. , New York, NY ...r than face another day of frustration and failure...
...s Benefit from Personalized Attention , , DENVER,...elbow specialist at Western Orthopaedics, speciali... everything from a 45-minute technique called shou...e American Academy of Orthopaedic Surgeons, there ...
...hing which preterm infants are at risk of developi...ain. A new study from the Sahlgrenska Academy, Uni...wing weekly weight development might replace the n.... Preterm infants are at increased risk of damage ...
... Children International,s Youth Health Corps ...ound the world at record rates! , , To view the ...wire.com/mnr/childreninternational/37664/ , , (P... completed training in order to teach their peers ...
...of the art Fujitsu PalmSecure(TM) Biometric Authen...ing, and patient information updating to revolutio...actices , , CHICAGO and SUNNYVALE, Calif., April ...Allscripts Patient Kiosk (TM), the next generat...
...nsulting and Siebel Systems involved with new inde...l 7 Univita Health, a new company aimed at promot...ependent aging, today announced the election of Ge...nd is joining us on our mission to help people liv...
Other Medicine News:Health News:Workers Comp Troubles Making You Sick? New York Personal Injury Lawyers Might Just Have the Cure 2Health News:Workers Comp Troubles Making You Sick? New York Personal Injury Lawyers Might Just Have the Cure 3Health News:Workers Comp Troubles Making You Sick? New York Personal Injury Lawyers Might Just Have the Cure 4Health News:Western Orthopaedics in Denver Blends Innovative Techniques to Provide a Spectrum of Shoulder Care 2Health News:Western Orthopaedics in Denver Blends Innovative Techniques to Provide a Spectrum of Shoulder Care 3Health News:New, simple method identifies preterm infants at risk of eye disease 2Health News:Photos: Report Shows Youth Health Educators Reach More Poor Teens with a Message of Living Healthy Lives! 2Health News:Allscripts Integrates Electronic Health Record With Innovative Patient Kiosk 2Health News:Allscripts Integrates Electronic Health Record With Innovative Patient Kiosk 3Health News:Allscripts Integrates Electronic Health Record With Innovative Patient Kiosk 4Health News:Allscripts Integrates Electronic Health Record With Innovative Patient Kiosk 5Health News:Allscripts Integrates Electronic Health Record With Innovative Patient Kiosk 6Health News:Allscripts Integrates Electronic Health Record With Innovative Patient Kiosk 7Health News:George T. Shaheen Joins Board of Directors at Univita Health 2
...is clinically proven to reduce the appearance of c...-gel formula combines Retinol, the purest form of ...orks deep within skin's surface to improve elastic... absorbing, it has a fresh, clean scent and leaves...
...been developed specifically to fight Cellulite in ... does this by stimulating and massaging the lymph ...ch then are removed naturally. Initially, we recom...each treatment. After noticing visible results, th...
Ritter 204 Manual Exam Table
DermMaster II Salt-A-Peel™ Microdermabrasion
Medicine Products: